Skip to main content
×
Home
    • Aa
    • Aa

Age-specific efficacy of pertussis vaccine during epidemic and non-epidemic periods

  • M. E. B. Ramsay (a1), C. P. Farrington (a1) and E. Miller (a1)
Abstract
Summary

A national survey was conducted of 3150 notified cases of whooping cough in order to determine age-specific pertussis vaccine efficacy by the ‘screening’ method. The cases were collected over two periods, one just prior to the start and one at the first peak of the whooping cough epidemic of 1989–90. Vaccination status was determined by a postal questionnaire to the reporting doctor and clinical data were also collected to provide efficacy estimates according to standardized case definitions. Overall, observed vaccine efficacy was high but differed between epidemic (87%) and non-epidemic (93%) periods (P = 0·03). Efficacy estimates were generally higher for typical or severe cases than for children with an atypical illness. Vaccine efficacy declined with age (P < 0·01) but estimates remained high up to the age of 8 years. This study will provide baseline data for comparison with efficacy observed from similar studies of children immunized at an accelerated schedule and from phase III studies of acellular pertussis vaccines performed elsewhere.

Copyright
Corresponding author
* Author for correspondence: Dr M. Ramsay, Department of Public Health Medicine, St Mary's Hospital Medical School, Imperial College, Norfolk Place, London W2 1PG.
Linked references
Hide All

This list contains references from the content that can be linked to their source. For a full set of references and notes please see the PDF or HTML where available.

2.MEB Ramsay , MJ Corbel , K Redhead , LAE Ashworth , NT Begg . Persistence of antibody after accelerated immunisation with diphtheria/tetanus/pertussis vaccine. BMJ 1991; 302: 1489–91.

3.R Booy , SJM Aitken , S Taylor , Immunogenicity of combined diphtheria, tetanus, and pertussis vaccine given at 2, 3 and 4 months of age versus 3, 5 and 9 months of age. Lancet 1992; 339: 507–10.

5.WC Blackwelder , J Storsaeter , P Olin , H Hallander . Acellular pertussis vaccines. Efficacy and evaluation of clinical case definitions. Amer J Dis Child 1991; 145: 16.

7.D Jenkinson . Duration of effectiveness of pertussis vaccine: evidence from a 10-year community study. BMJ 1988; 296: 612–14.

8.TM Pollock , E Miller , J Lobb . Severity of whooping cough in England before and after the decline in pertussis immunisation. Arch Dis Child 1984; 59: 162–5.

11.NT Begg , ON Gill , JM White . COVER (Cover of Vaccination Evaluated Rapidly): description of the England and Wales scheme. Public Health 1989; 103: 81–9.

13.IM Onorato , SGF Wassilak . Laboratory diagnosis of pertussis: the state of the art. Paediatr Infect Dis J 1987; 6: 145–51.

15.PR Grob , MJ Crowder , JF Robbins . Effect of vaccination on the severity and dissemination of whooping cough. BMJ 1981; 282: 1925–8.

16. Swansea Research Unit of the Royal College of General Practitioners. Effect of a low pertussis vaccination uptake on a large community. BMJ 1981; 282: 2336.

18.SR Palmer . Vaccine efficacy and control measures in pertussis. Arch Dis Child 1991; 66: 854–7.

20.PEM Fine , JA Clarkson . Reflections of the efficacy of pertussis vaccines. Rev Infect Dis 1987; 9: 866–83.

21.CP Farrington . The measurement and interpretation of age specific vaccine efficacy. Int J of Epidemiol 1992; 21: 1014–20.

Recommend this journal

Email your librarian or administrator to recommend adding this journal to your organisation's collection.

Epidemiology & Infection
  • ISSN: 0950-2688
  • EISSN: 1469-4409
  • URL: /core/journals/epidemiology-and-infection
Please enter your name
Please enter a valid email address
Who would you like to send this to? *
×

Metrics

Altmetric attention score